Scientists thought a marine climate cycle that influences U.S. weather was driven by natural factors. New research has turned that theory on its head.

The attorney general missed a June 7 deadline set by President Donald Trump to investigate state climate programs, easing fears of a federal crackdown.

The administration blacked out 27 pages of findings in a document the Interior secretary cited when he ordered a work stoppage on the offshore wind project.

A legal nonprofit group says the state transportation agency isn’t doing enough to implement New York’s climate law and reduce emissions.

State officials granted temporary protections to the Quino checkerspot, setting up a review — and a new flashpoint in the housing-versus-conservation fight.

Politicians blowing hot air won’t solve Britain’s record-breaking hot summers.

The study shows waves could reach Ahu Tongariki, the largest ceremonial platform on the island, as early as 2080.

Using artificial intelligence, MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies.

After training a machine-learning model to analyze thousands of existing delivery particles, the researchers used it to predict new materials that would work even better. The model also enabled the researchers to identify particles that would work well in different types of cells, and to discover ways to incorporate new types of materials into the particles.

“What we did was apply machine-learning tools to help accelerate the identification of optimal ingredient mixtures in lipid nanoparticles to help target a different cell type or help incorporate different materials, much faster than previously was possible,” says Giovanni Traverso, an associate professor of mechanical engineering at MIT, a gastroenterologist at Brigham and Women’s Hospital, and the senior author of the study.

This approach could dramatically speed the process of developing new RNA vaccines, as well as therapies that could be used to treat obesity, diabetes, and other metabolic disorders, the researchers say.

Alvin Chan, a former MIT postdoc who is now an assistant professor at Nanyang Technological University, and Ameya Kirtane, a former MIT postdoc who is now an assistant professor at the University of Minnesota, are the lead authors of the new open-access study, which appears today in Nature Nanotechnology.

Particle predictions

RNA vaccines, such as the vaccines for SARS-CoV-2, are usually packaged in lipid nanoparticles (LNPs) for delivery. These particles protect mRNA from being broken down in the body and help it to enter cells once injected.

Creating particles that handle these jobs more efficiently could help researchers to develop even more effective vaccines. Better delivery vehicles could also make it easier to develop mRNA therapies that encode genes for proteins that could help to treat a variety of diseases.

In 2024, Traverso’s lab launched a multiyear research program, funded by the U.S. Advanced Research Projects Agency for Health (ARPA-H), to develop new ingestible devices that could achieve oral delivery of RNA treatments and vaccines.

“Part of what we’re trying to do is develop ways of producing more protein, for example, for therapeutic applications. Maximizing the efficiency is important to be able to boost how much we can have the cells produce,” Traverso says.

A typical LNP consists of four components — a cholesterol, a helper lipid, an ionizable lipid, and a lipid that is attached to polyethylene glycol (PEG). Different variants of each of these components can be swapped in to create a huge number of possible combinations. Changing up these formulations and testing each one individually is very time-consuming, so Traverso, Chan, and their colleagues decided to turn to artificial intelligence to help speed up the process.

“Most AI models in drug discovery focus on optimizing a single compound at a time, but that approach doesn’t work for lipid nanoparticles, which are made of multiple interacting components,” Chan says. “To tackle this, we developed a new model called COMET, inspired by the same transformer architecture that powers large language models like ChatGPT. Just as those models understand how words combine to form meaning, COMET learns how different chemical components come together in a nanoparticle to influence its properties — like how well it can deliver RNA into cells.”

To generate training data for their machine-learning model, the researchers created a library of about 3,000 different LNP formulations. The team tested each of these 3,000 particles in the lab to see how efficiently they could deliver their payload to cells, then fed all of this data into a machine-learning model.

After the model was trained, the researchers asked it to predict new formulations that would work better than existing LNPs. They tested those predictions by using the new formulations to deliver mRNA encoding a fluorescent protein to mouse skin cells grown in a lab dish. They found that the LNPs predicted by the model did indeed work better than the particles in the training data, and in some cases better than LNP formulations that are used commercially.

Accelerated development

Once the researchers showed that the model could accurately predict particles that would efficiently deliver mRNA, they began asking additional questions. First, they wondered if they could train the model on nanoparticles that incorporate a fifth component: a type of polymer known as branched poly beta amino esters (PBAEs).

Research by Traverso and his colleagues has shown that these polymers can effectively deliver nucleic acids on their own, so they wanted to explore whether adding them to LNPs could improve LNP performance. The MIT team created a set of about 300 LNPs that also include these polymers, which they used to train the model. The resulting model could then predict additional formulations with PBAEs that would work better.

Next, the researchers set out to train the model to make predictions about LNPs that would work best in different types of cells, including a type of cell called Caco-2, which is derived from colorectal cancer cells. Again, the model was able to predict LNPs that would efficiently deliver mRNA to these cells.

Lastly, the researchers used the model to predict which LNPs could best withstand lyophilization — a freeze-drying process often used to extend the shelf-life of medicines.

“This is a tool that allows us to adapt it to a whole different set of questions and help accelerate development. We did a large training set that went into the model, but then you can do much more focused experiments and get outputs that are helpful on very different kinds of questions,” Traverso says.

He and his colleagues are now working on incorporating some of these particles into potential treatments for diabetes and obesity, which are two of the primary targets of the ARPA-H funded project. Therapeutics that could be delivered using this approach include GLP-1 mimics with similar effects to Ozempic.

This research was funded by the GO Nano Marble Center at the Koch Institute, the Karl van Tassel Career Development Professorship, the MIT Department of Mechanical Engineering, Brigham and Women’s Hospital, and ARPA-H.

Nature Climate Change, Published online: 15 August 2025; doi:10.1038/s41558-025-02405-y

Genetic diversity must be explicitly recognized in ecological restoration

Nature Climate Change, Published online: 15 August 2025; doi:10.1038/s41558-025-02385-z

Climate change is increasing financial impacts for households, yet flood insurance coverage remains insufficient. Now research affirms that there are still opportunities to substantially close the protection gap, in particular for disadvantaged groups.

Nature Climate Change, Published online: 15 August 2025; doi:10.1038/s41558-025-02396-w

Homeowners could benefit from flood insurance to offset the negative impacts of climate-induced natural disasters. However, with detailed micro-level data, researchers find substantial protection gaps and underinsurance across the USA that disproportionately affect low-income households.

The White House’s recently-unveiled “AI Action Plan” wages war on so-called “woke AI”—including large language models (LLMs) that provide information inconsistent with the administration’s views on climate change, gender, and other issues. It also targets measures designed to mitigate the generation of racial and gender biased content and even hate speech. The reproduction of this bias is a pernicious problem that AI developers have struggled to solve for over a decade.

A new executive order called “Preventing Woke AI in the Federal Government,” released alongside the AI Action Plan, seeks to strong-arm AI companies into modifying their models to conform with the Trump Administration’s ideological agenda.

The executive order requires AI companies that receive federal contracts to prove that their LLMs are free from purported “ideological biases” like “diversity, equity, and inclusion.” This heavy-handed censorship will not make models more accurate or “trustworthy,” as the Trump Administration claims, but is a blatant attempt to censor the development of LLMs and restrict them as a tool of expression and information access. While the First Amendment permits the government to choose to purchase only services that reflect government viewpoints, the government may not use that power to influence what services and information are available to the public. Lucrative government contracts can push commercial companies to implement features (or biases) that they wouldn't otherwise, and those often roll down to the user. Doing so would impact the 60 percent of Americans who get information from LLMs, and it would force developers to roll back efforts to reduce biases—making the models much less accurate, and far more likely to cause harm, especially in the hands of the government. 

Less Accuracy, More Bias and Discrimination

It’s no secret that AI models—including gen AI—tend to discriminate against racial and gender minorities. AI models use machine learning to identify and reproduce patterns in data that they are “trained” on. If the training data reflects biases against racial, ethnic, and gender minorities—which it often does—then the AI model will “learn” to discriminate against those groups. In other words, garbage in, garbage out. Models also often reflect the biases of the people who train, test, and evaluate them. 

This is true across different types of AI. For example, “predictive policing” tools trained on arrest data that reflects overpolicing of black neighborhoods frequently recommend heightened levels of policing in those neighborhoods, often based on inaccurate predictions that crime will occur there. Generative AI models are also implicated. LLMs already recommend more criminal convictions, harsher sentences, and less prestigious jobs for people of color. Despite that people of color account for less than half of the U.S. prison population, 80 percent of Stable Diffusion's AI-generated images of inmates have darker skin. Over 90 percent of AI-generated images of judges were men; in real life, 34 percent of judges are women. 

These models aren’t just biased—they’re fundamentally incorrect. Race and gender aren’t objective criteria for deciding who gets hired or convicted of a crime. Those discriminatory decisions reflected trends in the training data that could be caused by bias or chance—not some “objective” reality. Setting fairness aside, biased models are just worse models: they make more mistakes, more often. Efforts to reduce bias-induced errors will ultimately make models more accurate, not less. 

Biased LLMs Cause Serious Harm—Especially in the Hands of the Government

But inaccuracy is far from the only problem. When government agencies start using biased AI to make decisions, real people suffer. Government officials routinely make decisions that impact people’s personal freedom and access to financial resources, healthcare, housing, and more. The White House’s AI Action Plan calls for a massive increase in agencies’ use of LLMs and other AI—while all but requiring the use of biased models that automate systemic, historical injustice. Using AI simply to entrench the way things have always been done squanders the promise of this new technology.

We need strong safeguards to prevent government agencies from procuring biased, harmful AI tools. In a series of executive orders, as well as his AI Action Plan, the Trump Administration has rolled back the already-feeble Biden-era AI safeguards. This makes AI-enabled civil rights abuses far more likely, putting everyone’s rights at risk. 

And the Administration could easily exploit the new rules to pressure companies to make publicly available models worse, too. Corporations like healthcare companies and landlords increasingly use AI to make high-impact decisions about people, so more biased commercial models would also cause harm. 

We have argued against using machine learning to make predictive policing decisions or other punitive judgments for just these reasons, and will continue to protect your right not to be subject to biased government determinations influenced by machine learning.

Graphite is a key structural component in some of the world’s oldest nuclear reactors and many of the next-generation designs being built today. But it also condenses and swells in response to radiation — and the mechanism behind those changes has proven difficult to study.

Now, MIT researchers and collaborators have uncovered a link between properties of graphite and how the material behaves in response to radiation. The findings could lead to more accurate, less destructive ways of predicting the lifespan of graphite materials used in reactors around the world.

“We did some basic science to understand what leads to swelling and, eventually, failure in graphite structures,” says MIT Research Scientist Boris Khaykovich, senior author of the new study. “More research will be needed to put this into practice, but the paper proposes an attractive idea for industry: that you might not need to break hundreds of irradiated samples to understand their failure point.”

Specifically, the study shows a connection between the size of the pores within graphite and the way the material swells and shrinks in volume, leading to degradation.

“The lifetime of nuclear graphite is limited by irradiation-induced swelling,” says co-author and MIT Research Scientist Lance Snead. “Porosity is a controlling factor in this swelling, and while graphite has been extensively studied for nuclear applications since the Manhattan Project, we still do not have a clear understanding of the porosity in both mechanical properties and swelling. This work addresses that.”

The open-access paper appears this week in Interdisciplinary Materials. It is co-authored by Khaykovich, Snead, MIT Research Scientist Sean Fayfar, former MIT research fellow Durgesh Rai, Stony Brook University Assistant Professor David Sprouster, Oak Ridge National Laboratory Staff Scientist Anne Campbell, and Argonne National Laboratory Physicist Jan Ilavsky.

A long-studied, complex material

Ever since 1942, when physicists and engineers built the world’s first nuclear reactor on a converted squash court at the University of Chicago, graphite has played a central role in the generation of nuclear energy. That first reactor, dubbed the Chicago Pile, was constructed from about 40,000 graphite blocks, many of which contained nuggets of uranium.

Today graphite is a vital component of many operating nuclear reactors and is expected to play a central role in next-generation reactor designs like molten-salt and high-temperature gas reactors. That’s because graphite is a good neutron moderator, slowing down the neutrons released by nuclear fission so they are more likely to create fissions themselves and sustain a chain reaction.

“The simplicity of graphite makes it valuable,” Khaykovich explains. “It’s made of carbon, and it’s relatively well-known how to make it cleanly. Graphite is a very mature technology. It’s simple, stable, and we know it works.”

But graphite also has its complexities.

“We call graphite a composite even though it’s made up of only carbon atoms,” Khaykovich says. “It includes ‘filler particles’ that are more crystalline, then there is a matrix called a ‘binder’ that is less crystalline, then there are pores that span in length from nanometers to many microns.”

Each graphite grade has its own composite structure, but they all contain fractals, or shapes that look the same at different scales.

Those complexities have made it hard to predict how graphite will respond to radiation in microscopic detail, although it’s been known for decades that when graphite is irradiated, it first densifies, reducing its volume by up to 10 percent, before swelling and cracking. The volume fluctuation is caused by changes to graphite’s porosity and lattice stress.

“Graphite deteriorates under radiation, as any material does,” Khaykovich says. “So, on the one hand we have a material that’s extremely well-known, and on the other hand, we have a material that is immensely complicated, with a behavior that’s impossible to predict through computer simulations.”

For the study, the researchers received irradiated graphite samples from Oak Ridge National Laboratory. Co-authors Campbell and Snead were involved in irradiating the samples some 20 years ago. The samples are a grade of graphite known as G347A.

The research team used an analysis technique known as X-ray scattering, which uses the scattered intensity of an X-ray beam to analyze the properties of material. Specifically, they looked at the distribution of sizes and surface areas of the sample’s pores, or what are known as the material’s fractal dimensions.

“When you look at the scattering intensity, you see a large range of porosity,” Fayfar says. “Graphite has porosity over such large scales, and you have this fractal self-similarity: The pores in very small sizes look similar to pores spanning microns, so we used fractal models to relate different morphologies across length scales.”

Fractal models had been used on graphite samples before, but not on irradiated samples to see how the material’s pore structures changed. The researchers found that when graphite is first exposed to radiation, its pores get filled as the material degrades.

“But what was quite surprising to us is the [size distribution of the pores] turned back around,” Fayfar says. “We had this recovery process that matched our overall volume plots, which was quite odd. It seems like after graphite is irradiated for so long, it starts recovering. It’s sort of an annealing process where you create some new pores, then the pores smooth out and get slightly bigger. That was a big surprise.”

The researchers found that the size distribution of the pores closely follows the volume change caused by radiation damage.

“Finding a strong correlation between the [size distribution of pores] and the graphite’s volume changes is a new finding, and it helps connect to the failure of the material under irradiation,” Khaykovich says. “It’s important for people to know how graphite parts will fail when they are under stress and how failure probability changes under irradiation.”

From research to reactors

The researchers plan to study other graphite grades and explore further how pore sizes in irradiated graphite correlate with the probability of failure. They speculate that a statistical technique known as the Weibull Distribution could be used to predict graphite’s time until failure. The Weibull Distribution is already used to describe the probability of failure in ceramics and other porous materials like metal alloys.

Khaykovich also speculated that the findings could contribute to our understanding of why materials densify and swell under irradiation.

“There’s no quantitative model of densification that takes into account what’s happening at these tiny scales in graphite,” Khaykovich says. “Graphite irradiation densification reminds me of sand or sugar, where when you crush big pieces into smaller grains, they densify. For nuclear graphite, the crushing force is the energy that neutrons bring in, causing large pores to get filled with smaller, crushed pieces. But more energy and agitation create still more pores, and so graphite swells again. It’s not a perfect analogy, but I believe analogies bring progress for understanding these materials.”

The researchers describe the paper as an important step toward informing graphite production and use in nuclear reactors of the future.

“Graphite has been studied for a very long time, and we’ve developed a lot of strong intuitions about how it will respond in different environments, but when you’re building a nuclear reactor, details matter,” Khaykovich says. “People want numbers. They need to know how much thermal conductivity will change, how much cracking and volume change will happen. If components are changing volume, at some point you need to take that into account.”

This work was supported, in part, by the U.S. Department of Energy.

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA).

Using generative AI algorithms, the research team designed more than 36 million possible compounds and computationally screened them for antimicrobial properties. The top candidates they discovered are structurally distinct from any existing antibiotics, and they appear to work by novel mechanisms that disrupt bacterial cell membranes.

This approach allowed the researchers to generate and evaluate theoretical compounds that have never been seen before — a strategy that they now hope to apply to identify and design compounds with activity against other species of bacteria.

“We’re excited about the new possibilities that this project opens up for antibiotics development. Our work shows the power of AI from a drug design standpoint, and enables us to exploit much larger chemical spaces that were previously inaccessible,” says James Collins, the Termeer Professor of Medical Engineering and Science in MIT’s Institute for Medical Engineering and Science (IMES) and Department of Biological Engineering.

Collins is the senior author of the study, which appears today in Cell. The paper’s lead authors are MIT postdoc Aarti Krishnan, former postdoc Melis Anahtar ’08, and Jacqueline Valeri PhD ’23.

Exploring chemical space

Over the past 45 years, a few dozen new antibiotics have been approved by the FDA, but most of these are variants of existing antibiotics. At the same time, bacterial resistance to many of these drugs has been growing. Globally, it is estimated that drug-resistant bacterial infections cause nearly 5 million deaths per year.

In hopes of finding new antibiotics to fight this growing problem, Collins and others at MIT’s Antibiotics-AI Project have harnessed the power of AI to screen huge libraries of existing chemical compounds. This work has yielded several promising drug candidates, including halicin and abaucin.

To build on that progress, Collins and his colleagues decided to expand their search into molecules that can’t be found in any chemical libraries. By using AI to generate hypothetically possible molecules that don’t exist or haven’t been discovered, they realized that it should be possible to explore a much greater diversity of potential drug compounds.

In their new study, the researchers employed two different approaches: First, they directed generative AI algorithms to design molecules based on a specific chemical fragment that showed antimicrobial activity, and second, they let the algorithms freely generate molecules, without having to include a specific fragment.

For the fragment-based approach, the researchers sought to identify molecules that could kill N. gonorrhoeae, a Gram-negative bacterium that causes gonorrhea. They began by assembling a library of about 45 million known chemical fragments, consisting of all possible combinations of 11 atoms of carbon, nitrogen, oxygen, fluorine, chlorine, and sulfur, along with fragments from Enamine’s REadily AccessibLe (REAL) space.

Then, they screened the library using machine-learning models that Collins’ lab has previously trained to predict antibacterial activity against N. gonorrhoeae. This resulted in nearly 4 million fragments. They narrowed down that pool by removing any fragments predicted to be cytotoxic to human cells, displayed chemical liabilities, and were known to be similar to existing antibiotics. This left them with about 1 million candidates.

“We wanted to get rid of anything that would look like an existing antibiotic, to help address the antimicrobial resistance crisis in a fundamentally different way. By venturing into underexplored areas of chemical space, our goal was to uncover novel mechanisms of action,” Krishnan says.

Through several rounds of additional experiments and computational analysis, the researchers identified a fragment they called F1 that appeared to have promising activity against N. gonorrhoeae. They used this fragment as the basis for generating additional compounds, using two different generative AI algorithms.

One of those algorithms, known as chemically reasonable mutations (CReM), works by starting with a particular molecule containing F1 and then generating new molecules by adding, replacing, or deleting atoms and chemical groups. The second algorithm, F-VAE (fragment-based variational autoencoder), takes a chemical fragment and builds it into a complete molecule. It does so by learning patterns of how fragments are commonly modified, based on its pretraining on more than 1 million molecules from the ChEMBL database.

Those two algorithms generated about 7 million candidates containing F1, which the researchers then computationally screened for activity against N. gonorrhoeae. This screen yielded about 1,000 compounds, and the researchers selected 80 of those to see if they could be produced by chemical synthesis vendors. Only two of these could be synthesized, and one of them, named NG1, was very effective at killing N. gonorrhoeae in a lab dish and in a mouse model of drug-resistant gonorrhea infection.

Additional experiments revealed that NG1 interacts with a protein called LptA, a novel drug target involved in the synthesis of the bacterial outer membrane. It appears that the drug works by interfering with membrane synthesis, which is fatal to cells.

Unconstrained design

In a second round of studies, the researchers explored the potential of using generative AI to freely design molecules, using Gram-positive bacteria, S. aureus as their target.

Again, the researchers used CReM and VAE to generate molecules, but this time with no constraints other than the general rules of how atoms can join to form chemically plausible molecules. Together, the models generated more than 29 million compounds. The researchers then applied the same filters that they did to the N. gonorrhoeae candidates, but focusing on S. aureus, eventually narrowing the pool down to about 90 compounds.

They were able to synthesize and test 22 of these molecules, and six of them showed strong antibacterial activity against multi-drug-resistant S. aureus grown in a lab dish. They also found that the top candidate, named DN1, was able to clear a methicillin-resistant S. aureus (MRSA) skin infection in a mouse model. These molecules also appear to interfere with bacterial cell membranes, but with broader effects not limited to interaction with one specific protein.

Phare Bio, a nonprofit that is also part of the Antibiotics-AI Project, is now working on further modifying NG1 and DN1 to make them suitable for additional testing.

“In a collaboration with Phare Bio, we are exploring analogs, as well as working on advancing the best candidates preclinically, through medicinal chemistry work,” Collins says. “We are also excited about applying the platforms that Aarti and the team have developed toward other bacterial pathogens of interest, notably Mycobacterium tuberculosis and Pseudomonas aeruginosa.”

The research was funded, in part, by the U.S. Defense Threat Reduction Agency, the National Institutes of Health, the Audacious Project, Flu Lab, the Sea Grape Foundation, Rosamund Zander and Hansjorg Wyss for the Wyss Foundation, and an anonymous donor.

Here’s an interesting story about a failure being introduced by LLM-written code. Specifically, the LLM was doing some code refactoring, and when it moved a chunk of code from one file to another it changed a “break” to a “continue.” That turned an error logging statement into an infinite loop, which crashed the system.

This is an integrity failure. Specifically, it’s a failure of processing integrity. And while we can think of particular patches that alleviate this exact failure, the larger problem is much harder to solve.

Davi Ottenheimer ...

America swapped places with China as coal sees a minirevival in the U.S. In China, renewable energy is surging.

Electric utilities urged the agency to preserve its ability to regulate power plants for greenhouse gases.

The move comes two months before 108 nations will vote on the emissions fee.

A report suggests ways agencies could oversee a system that lets polluters fund climate projects and get credit for offsetting their own emissions.

Two panel members have raised concerns about climate plans and want the Public Service Commission to hold a hearing to defer key deadlines.